佰金生命科学(01466)因转换可换股债券发行1.199亿股

Core Viewpoint - Baijin Life Sciences (01466) announced the issuance of 119.9 million shares following the exercise of conversion rights attached to convertible bonds worth HKD 31.5 million at a conversion price of HKD 0.2628 per share [1] Group 1 - The company received a conversion notice from bondholders on September 29, 2025 [1] - The newly issued shares represent approximately 15.52% of the company's existing issued share capital and about 13.43% of the enlarged issued share capital after the issuance [1] - The shares were allocated and issued to bondholders on October 8, 2025 [1]